CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Net Inc. Y/Y Annual
Utah Medical Products Inc  (NASDAQ: UTMD)
Other Ticker:  
 
 

UTMD's Net Income Growth by Quarter and Year

Utah Medical Products Inc's Net Income results by quarter and year

 



UTMD Net Income (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December - 2.16 4.20 4.10
3rd Quarter September - 3.56 4.21 3.53
2nd Quarter June - 3.96 4.56 4.13
1st Quarter March 3.04 3.94 4.28 4.21
FY   3.04 13.62 17.25 15.97

UTMDs Annual Net Income
Utah Medical Products Inc's Net Income in the fiscal year 2024 $ 13.87 millions
Utah Medical Products Inc's Net Income in the fiscal year 2023 $ 16.64 millions
Utah Medical Products Inc's Net Income in the fiscal year 2022 $ 16.47 millions
Utah Medical Products Inc's Net Income in the fiscal year 2021 $ 14.79 millions
Utah Medical Products Inc's Net Income in the fiscal year 2020 $ 10.80 millions




UTMD Net Income first quarter 2025 Y/Y Growth Comment
Utah Medical Products Inc reported decline in Net Income in the first quarter 2025 by -22.82% to $ 3.04 millions, from the same quarter in 2024.
The contraction in the first quarter 2025 Utah Medical Products Inc's Net Income compares unfavorably to the Company's average Net Income growth of 6.7%.

Looking into first quarter 2025 results within Medical Equipment & Supplies industry 28 other companies have achieved higher Net Income growth. While Utah Medical Products Inc' s Net Income fall of -22.82% ranks overall at the positon no. 1213 in the first quarter 2025.


UTMD Net Income ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - -48.57 % 2.44 % 19.53 %
3rd Quarter September - -15.44 % 19.26 % 16.89 %
2nd Quarter June - -13.16 % 10.41 % 21.11 %
1st Quarter March -22.82 % -7.94 % 1.66 % 43.69 %
FY   - -21.04 % 8.02 % 24.86 %

Financial Statements
Utah Medical Products Inc's first quarter 2025 Net Income $ 3.04 millions UTMD's Income Statement
Utah Medical Products Inc's first quarter 2024 Net Income $ 3.94 millions Quarterly UTMD's Income Statement


UTMD Net Income (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - -39.33 % -0.24 % 16.15 %
3rd Quarter September - -10.1 % -7.68 % -14.53 %
2nd Quarter June - 0.51 % 6.54 % -1.9 %
1st Quarter March 40.79 % -6.19 % 4.39 % 22.74 %
FY (Year on Year)   - -21.04 % 8.02 % 24.86 %


Compare UTMD Profitability >> Back to UTMD Growth rate Comparisons >>


Net Income first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #29
Healthcare Sector #82
Overall #1213

Net Income Y/Y Growth Statistics
High Average Low
160.93 % 6.7 % -62.75 %
 
Net Income first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #29
Healthcare Sector #82
Overall #1213
Net Income Y/Y Growth Statistics
High Average Low
160.93 % 6.7 % -62.75 %
 

Net Income by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Utah Medical Products Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
123.38 % 3.68 % -58.18 %
(Sep 30 2020)  


UTMD's I. Quarter Q/Q Net Income Comment
Utah Medical Products Inc achieved in the I. Quarter 2025 above company average sequential Net Income jump of 40.79%, to $ 3.04 millions, from $2.16 millions in the forth quarter.
Medical Equipment & Supplies company is going from strength to strength, not only claiming higher then regular growth, but also increasing speed.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Net Income quarter on quarter growth. While Utah Medical Products Inc's Net Income growth quarter on quarter, overall rank is 299.


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #30
Overall #299
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #30
Overall #299
Net Income Q/Q Growth Statistics
High Average Low
123.38 % 3.68 % -58.18 %
(Sep 30 2020)  


UTMD's I. Quarter Q/Q Net Income Comment
Utah Medical Products Inc achieved in the I. Quarter 2025 above company average sequential Net Income jump of 40.79%, to $ 3.04 millions, from $2.16 millions in the forth quarter.
Medical Equipment & Supplies company is undergoing a remarkable growth, with reporting higher then regular gain, but also accelerating speed.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Net Income quarter on quarter growth. While Utah Medical Products Inc's Net Income growth quarter on quarter, overall rank is 299.


Utah Medical Products Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)
Cumulative Net Income 12 Months Ending $ 12.72 $ 13.62 $ 15.66 $ 16.31 $ 16.91
Y / Y Net Income Growth (TTM) -24.81 % -21.07 % -8.7 % -0.98 % 5.37 %
Year on Year Net Income Growth Overall Ranking # 1237 # 1546 # 1194 # # 1011
Seqeuential Net Income Change (TTM) -6.61 % -13.06 % -3.99 % -3.55 % -1.97 %
Seq. Net Income Growth (TTM) Overall Ranking # 1237 # 1546 # 1194 # # 1011


Cumulative Net Income growth Comment
Utah Medical Products Inc's cumulative 12 months Net Income continue to fall, but on the faster rate at -24.81% year on year, at Mar 31 2025 compare to the -21.07% decrease at Dec 31 2024. If the Utah Medical Products Inc's fiscal year would end at Mar 31 2025, annual Net Income would be $13 millions.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1237, from total ranking in previous quarter at 1546.

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 18
Healthcare Sector # 59
Overall # 783

Net Income TTM Y/Y Growth Statistics
High Average Low
118.17 %
 6.68 %
-29.87 %
(Dec 31 2018)  


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 19
Sector # 66
S&P 500 # 936
Cumulative Net Income growth Comment
Utah Medical Products Inc's cumulative 12 months Net Income continue to fall, but on the faster rate at -24.81% year on year, at Mar 31 2025 compare to the -21.07% decrease at Dec 31 2024. If the Utah Medical Products Inc's fiscal year would end at Mar 31 2025, annual Net Income would be $13 millions.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1237, from total ranking in previous quarter at 1546.


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 18
Healthcare Sector # 59
Overall # 783

Net Income TTM Y/Y Growth Statistics
High Average Low
118.17 %
6.68 %
-29.87 %
(Dec 31 2018)  


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 19
Sector # 66
S&P 500 # 936




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
UTMD's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for UTMD's Competitors
Net Income Growth for Utah Medical Products Inc's Suppliers
Net Income Growth for UTMD's Customers

You may also want to know
UTMD's Annual Growth Rates UTMD's Profitability Ratios UTMD's Asset Turnover Ratio UTMD's Dividend Growth
UTMD's Roe UTMD's Valuation Ratios UTMD's Financial Strength Ratios UTMD's Dividend Payout Ratio
UTMD's Roa UTMD's Inventory Turnover Ratio UTMD's Growth Rates UTMD's Dividend Comparisons



Companies with similar Net Income fall for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2025
Pfizer Inc-4.80%$ -4.803 millions
Abbvie Inc -6.05%$ -6.050 millions
Incyte Corporation-6.69%$ -6.691 millions
Labcorp Holdings Inc -6.70%$ -6.702 millions
National Research Corporation-9.00%$ -8.995 millions
Progyny Inc -10.88%$ -10.883 millions
Align Technology inc -11.23%$ -11.233 millions
Iqvia Holdings Inc -13.54%$ -13.542 millions
Ani Pharmaceuticals Inc-13.87%$ -13.874 millions
Embecta Corp -18.69%$ -18.685 millions
West Pharmaceutical Services Inc -22.12%$ -22.116 millions
Utah Medical Products Inc-23.13%$ -23.129 millions
Envista Holdings Corporation-23.73%$ -23.729 millions
Davita Inc -24.11%$ -24.107 millions
Mimedx Group Inc -24.17%$ -24.166 millions
Carlisle Companies Incorporated-25.48%$ -25.481 millions
Corcept Therapeutics Inc-26.26%$ -26.263 millions
Dexcom Inc -28.01%$ -28.005 millions
Insulet Corporation-31.26%$ -31.262 millions
Select Medical Holdings Corp-36.22%$ -36.218 millions
Biogen Inc -38.87%$ -38.866 millions
Alkermes Plc -39.00%$ -39.003 millions
Vertex Pharmaceuticals Inc-41.22%$ -41.224 millions
Amphastar Pharmaceuticals Inc -41.44%$ -41.439 millions
Solventum Corporation-42.19%$ -42.194 millions
Becton Dickinson And Company-42.64%$ -42.644 millions
Lantheus Holdings Inc -44.34%$ -44.345 millions
Pacira Biosciences inc -46.41%$ -46.408 millions
Organon and Co -56.72%$ -56.716 millions
Gyre Therapeutics Inc -62.42%$ -62.416 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com